Intrapericardial delivery of anti-arrhythmic agents.
2009-05
Title
Intrapericardial delivery of anti-arrhythmic agents.
Authors
Published Date
2009-05
Publisher
Type
Thesis or Dissertation
Abstract
Anti-arrhythmic agents are known for their narrow therapeutic window and common side effects. Delivery of anti-arrhythmic agents into the pericardium has shown to increase their efficacy and minimize their side effects. My work has focused on evaluating the clinical potential of intrapericardial (IP) anti-arrhythmic delivery. This has included working with physicians to identify appropriate clinical applications, developing devices to aid in pericardial drug delivery, and carrying out several large animal studies to test efficacy. In swine models of sinus tachycardia, atrial fibrillation, and ischemia-induced ventricular tachycardias, we have shown the pharmacodynamic benefits of IP-delivered metoprolol, amiodarone, and docosahexaenoic acid. Pharmacokinetic data show that minimal amounts of drug reach the systemic circulation. We propose that IP delivery of anti-arrhythmic agents has potential to maximize therapeutic benefits while minimizing side effects, particularly in the settings of post-operative atrial fibrillation and inappropriate sinus tachycardia.
Description
University of Minnesota Ph.D. dissertation. May 2009. Major: Biomedical Engineering. Advisor: Paul A. Iaizzo, PhD.
Professor of Surgery, Integrative Biology and Physiology, and Anesthesiology. 1 computer file (PDF); x, 240 pages. Ill. (some col.)
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Richardson, Eric Stephen. (2009). Intrapericardial delivery of anti-arrhythmic agents.. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/52393.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.